MRKR Marker Therapeutics Inc
Company Analysis
Latest News
🟢 Marker Therapeutics is trading 5.8% up in after-hours trading
Marker Therapeutics is trading at $1.10, up 5.77% after hours, with the catalyst unclear. - It rose 13.04% in the regular session on October 16, closing at...
🟢 Marker Therapeutics is trading 14.13% up today amid a biotech sector rally
Marker Therapeutics is trading at $1.05, up 14.13%, amid a biotech sector rally. - The XBI was up 2.20% in regular trading, supporting a sector explanation...
🟢 Marker Therapeutics is trading 7.8% up in pre-market
Marker Therapeutics is trading at $0.99, up 7.77% in pre-market, with no clear company-specific catalyst identified. - The gain follows a 3.35% rise at the...
🟢 Marker Therapeutics is trading 6.4% up in after-hours trading — no clear catalyst identified
Marker Therapeutics is trading at $0.98, up +6.41%, and available evidence does not establish a specific reason for its October 15 after-hours move. - The...
🟢 Marker Therapeutics is trading 7.5% up on October 15, 2026 — no clear company-specific catalyst identified
Marker Therapeutics is trading at $0.96, up 7.52%, with no clear company-specific catalyst identified. - Marker Therapeutics’ investor-relations page lists...
🔴 Marker Therapeutics is trading 5.9% down today amid biotech-sector weakness
Marker Therapeutics is trading 5.89% lower at $0.95, in line with biotech-sector weakness; no company-specific catalyst was identified. - No new...
🟢 Marker Therapeutics is trading 6% up; no catalyst identified
Marker Therapeutics is trading at $1.03, up 6.01%, with the gain unexplained. - No October 12 company-specific catalyst was identified; the investor-relations...
🟢 Marker Therapeutics is trading 5% up in pre-market
Marker Therapeutics is trading at $1.00, up +5.22%, with no new company-specific announcement reported for October 9. - Shares closed October 8 at $0.95; the...
🔴 Marker Therapeutics is trading 5.28% down today amid broader biotech weakness
Marker Therapeutics is trading at $0.99, down 5.28%, with the decline appearing consistent with broader biotech weakness. - No company-specific announcement...
🔴 Marker Therapeutics is trading 5% down today amid broad biotech-sector weakness
Marker Therapeutics is trading 5.27% lower at $1.00, with broad biotech weakness the clearest available explanation. - No company-specific news was identified...
🔴 Marker Therapeutics is trading 5.6% down today
Marker Therapeutics is trading 5.6% lower at $1.01; available company news identifies no new catalyst for October 1. - Its latest listed press release, dated...
🔴 Marker Therapeutics is trading 6.08% down today amid broader pressure from oil and inflation concerns
Marker Therapeutics is trading at $1.08, down 6.08%, with no confirmed company-specific explanation for the decline. - No September 28 company-specific...
🟢 Marker Therapeutics is trading 7% up in after-hours trading with no identified company-specific news
Marker Therapeutics is trading 6.96% up at $1.23 after closing at $1.15 on September 25, 2026, with no identified company-specific news explaining the...
🔴 Marker Therapeutics is trading 5.65% down today amid biotech-sector weakness
Marker Therapeutics is trading 5.65% down now at $1.17 as biotechnology stocks weakened during the September 24, 2026 session. - The XBI sector benchmark was...
🟢 Marker Therapeutics is trading 5.65% up today amid expanded MT-601 manufacturing infrastructure update
Marker Therapeutics is trading at $1.31, up 5.65%; its recently highlighted expanded manufacturing infrastructure for MT-601 is the most relevant...
🟢 Marker Therapeutics is trading 9% up in pre-market with expanded MT-601 manufacturing support highlighted
Marker Therapeutics is trading at $1.33, up 8.99% in pre-market after highlighting expanded manufacturing support for its MT-601 program; direct causation is...
🟢 Marker Therapeutics rises 6.1% — Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🟢 Marker Therapeutics is trading 5.57% up in pre-market
Marker Therapeutics is trading at $1.24, up 5.57% in pre-market on September 16, 2026, after rising from the September 15 close of $1.17. - No fresh...
🟢 Marker Therapeutics is trading 6.96% up today — move remains unexplained
Marker Therapeutics is trading 6.96% up at $1.23, despite the broader market moving lower on September 14, 2026; the move remains unexplained. - No credible...
🟢 Marker Therapeutics is trading 6.96% up in after-hours trading as major indexes gained more than 0.5%
Marker Therapeutics is trading 6.96% up at $1.23 in after-hours trading, apparently amid broader risk-on sentiment rather than a confirmed company catalyst. -...